HomeCompareTSSNF vs EPRT

TSSNF vs EPRT: Dividend Comparison 2026

TSSNF yields 40000.00% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TSSNF wins by $5.18024517379999e+22M in total portfolio value
10 years
TSSNF
TSSNF
● Live price
40000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.18024517379999e+22M
Annual income
$51,548,940,318,215,365,000,000,000,000.00
Full TSSNF calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — TSSNF vs EPRT

📍 TSSNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTSSNFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TSSNF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TSSNF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TSSNF
Annual income on $10K today (after 15% tax)
$3,400,000.00/yr
After 10yr DRIP, annual income (after tax)
$43,816,599,270,483,060,000,000,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, TSSNF beats the other by $43,816,599,270,483,060,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TSSNF + EPRT for your $10,000?

TSSNF: 50%EPRT: 50%
100% EPRT50/50100% TSSNF
Portfolio after 10yr
$2.590122586899995e+22M
Annual income
$25,774,470,159,107,683,000,000,000,000.00/yr
Blended yield
99.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

TSSNF
No analyst data
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TSSNF buys
0
EPRT buys
0
No recent congressional trades found for TSSNF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTSSNFEPRT
Forward yield40000.00%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$5.18024517379999e+22M$64.3K
Annual income after 10y$51,548,940,318,215,365,000,000,000,000.00$13,170.85
Total dividends collected$5.178579568047658e+22M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: TSSNF vs EPRT ($10,000, DRIP)

YearTSSNF PortfolioTSSNF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$4,010,700$4,000,000.00$11,212$512.01+$4.00MTSSNF
2$1,503,618,552$1,499,327,102.80$12,689$692.09+$1503.61MTSSNF
3$526,936,342,129$525,327,470,278.19$14,521$944.30+$526936.33MTSSNF
4$172,618,628,820,566$172,054,806,934,488.28$16,841$1,302.88+$172618628.80MTSSNF
5$52,860,672,107,805,460$52,675,970,174,967,450.00$19,841$1,821.64+$52860672107.79MTSSNF
6$15,132,132,379,588,594,000$15,075,571,460,433,242,000.00$23,818$2,587.47+$15132132379588.57MTSSNF
7$4,049,462,878,006,525,600,000$4,033,271,496,360,366,000,000.00$29,230$3,744.65+$4049462878006525.50MTSSNF
8$1,013,053,710,099,385,500,000,000$1,008,720,784,819,918,400,000,000.00$36,816$5,540.38+$1013053710099385472.00MTSSNF
9$236,926,560,546,299,530,000,000,000$235,842,593,076,493,200,000,000,000.00$47,806$8,413.17+$236926560546299510784.00MTSSNF
10$51,802,451,737,999,890,000,000,000,000$51,548,940,318,215,365,000,000,000,000.00$64,324$13,170.85+$5.18024517379999e+22MTSSNF

TSSNF vs EPRT: Complete Analysis 2026

TSSNFStock

Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United States and internationally. It operates through BioSurgery, Orthopaedics & Dental, and GBM-V & Cardiac divisions. The company provides dCELL technology, a soft tissue decellularisation process that removes DNA and cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductive to stimulate and regenerate native bone growth. In addition, the company provides DermaPure, a decellularised dermal allograft for reinforcement, repair, and replacement of damaged or inadequate integumental tissue and other homologous uses of human integument; and SurgiPure XD, Decellularised porcine dermal reconstructive tissue matrix for the repair of hernias and body wall defects. Further, it offers OrthoPure XT, a scaffold to replace the damaged tissue that will re-populate with the patient's own cells; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft, which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Additionally, the company provides DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; CardioPure products; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks for ophthalmology and wound covering; and sports medicine products. The company was incorporated in 2006 and is based in Garforth, the United Kingdom.

Full TSSNF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this TSSNF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TSSNF vs SCHDTSSNF vs JEPITSSNF vs OTSSNF vs KOTSSNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.